Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron dosing strategies and monocyte function in hemodialysis patients
2019-002195-14Phase 4Active
- Sponsor
- Hospital Universitario Príncipe de Asturias
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Iron in anemia of renal disease (2 arms), sponsored by Hospital Universitario Príncipe de Asturias. Primary endpoint: Change in monocyte subpopulation proportions. Started Jul 2019; status: active.
02
Drugs
Iron
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2019-002195-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002195-14.